SHARON PLON to Xenograft Model Antitumor Assays
This is a "connection" page, showing publications SHARON PLON has written about Xenograft Model Antitumor Assays.
Connection Strength
0.167
-
Genomic analysis and preclinical xenograft model development identify potential therapeutic targets for MYOD1-mutant soft-tissue sarcoma of childhood. J Pathol. 2021 09; 255(1):52-61.
Score: 0.142
-
Current state of pediatric sarcoma biology and opportunities for future discovery: A report from the sarcoma translational research workshop. Cancer Genet. 2016 05; 209(5):182-94.
Score: 0.025